Results 241 to 250 of about 1,494,935 (289)
Some of the next articles are maybe not open access.
New Inhibitor of Platelet Aggregation in Onion Oil.
Lancet, The, 1988Shunro Kawakishi, Yasujiro Morimitsu
exaly +3 more sources
Hypopigmentation in Dogs Treated with an Inhibitor of Platelet Aggregation
Toxicologic Pathology, 1989Hypopigmentation was the principal manifestation of systemic toxicity when the experimental platelet aggregation inhibitor, PD-89454, was orally administered to Beagle dogs for 28 days. Pigmentation changes were present in skin of nose, lips and eyelids and mucosa of hard palate.
K M, Walsh, A W, Gough
openaire +2 more sources
Inhibitors of “spontaneous” platelet aggregation in whole blood
Atherosclerosis, 1985In vitro 'spontaneous' platelet aggregation has been studied in whole blood. The spectrum of activity of materials known to influence platelet aggregation in platelet-rich plasma proved different in whole blood. Thus dipyridamole and one of its analogues SH1242 had a striking effect in whole blood whilst aspirin, chlorpromazine and K3920 had little or ...
M J, Harrison +3 more
openaire +2 more sources
Lebetin Peptides: Potent Platelet Aggregation Inhibitors
Pathophysiology of Haemostasis and Thrombosis, 2001Lebetins from <i>Macrovipera lebetina</i> snake venom constitute a new class of inhibitors of platelet aggregation. There are two groups of peptides: lebetin 1 (L1; 11- to 13-mer) and lebetin 2 (L2; 37- to 38-mer). The short lebetins are identical to the N-terminal segments of the longer ones.
N, Marrakchi +6 more
openaire +2 more sources
Bleeding in a Patient Receiving Platelet Aggregation Inhibitors
Anesthesia & Analgesia, 2001We describe a patient who experienced intraoperative bleeding after being treated with platelet receptor glycoprotein IIb/IIIa antagonist eptifibatide. We used Sonoclot and Thrombelastograph to monitor antiplatelet effects of eptifibatide.
J H, Waters +3 more
openaire +2 more sources
Platelet turnover in metastatic cancer and the effect of platelet aggregation inhibitors
Zeitschrift f�r Krebsforschung und Klinische Onkologie, 1976Patients with metastatic cancer have a permanent shortening of platelet survival and increased platelet consumption. Acetylsalicylic acid or dipyridamole in doses known to inhibit platelet aggregation, had no effect on platelet consumption.
openaire +2 more sources

